Google
IRTC 株価分析 — IRHYTHM TECHNOLOGIES INC (Healthcare >> Medical Devices)
IRTC に関するよくある質問
IRTCのPER（株価収益率）は？
IRHYTHM TECHNOLOGIES INC（IRTC）は現在PER 701.43倍で取引されています。
IRTCのROE（自己資本利益率）は？
IRHYTHM TECHNOLOGIES INCのROEは-17.23%です。
IRTCの配当利回りは？
IRHYTHM TECHNOLOGIES INCの配当利回りは0.00%です。
IRTCの品質スコア（Quality Score）は？
当社のAIはIRTCの総合財務品質を100点中38点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
IRTCは今が買い時ですか？
当社AIのタイミングスコアは100点中64点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
IRTCはどのセクターに属しますか？
IRHYTHM TECHNOLOGIES INCはHealthcare >> Medical Devicesセクターに分類されます（NASDAQ市場）
IRTC AI Analysis Summary
Our AI summary for IRTC: IRHYTHM TECHNOLOGIES INC (NASDAQ), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 701.43, ROE of -17.23%, a dividend yield of 0.00%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 64/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 117.17
Price
-1.91
(-1.60%)
Day Change
|
|
|---|
IRTC, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
P/Eが高い。割高銘柄。
ROEが低い
ROAが低い
ROEの伸びが低い
平均ROEが低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
42% |
| In Recommendations? | In "Invest - GROWTH" Section |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 98 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 117.17 |
| PBV / Sector |
24.27 / -101.57
|
| Earning Per Share | -0.83 |
| PE / Sector |
701.43 / 31.23
|
| PEG or PE/Growth / Sector |
-31.08 / 0.40
|
| Average 1M Daily Value |
62.20 M
|
| Average 1W Daily Value |
71.14 M
|
| Timing Factors |
|
71% |
| Financial Health |
|
37% |
| ポイントになる統計 |
|
54% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-01 08:00:02 |
| Symbol | IRTC |
| Name | IRHYTHM TECHNOLOGIES INC |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 32.86 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 3,913.26 / 20,104.97 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 699 8th Street, San Francisco, CA, United States, 94103
Phone: 415 632 5700
Website: https://www.irhythmtech.com
Employees: 2,400
Sector: Healthcare >> Medical Devices
Description: iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data. In addition, the company offers Zio AT System, a prescription-only remote ECG monitoring system, which consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days, as well as incorporates the Zio AT wireless gateway to provide connectivity between the patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with BioIS to develop and commercialize pulse oximetry, accelerometry, and trending non-invasive blood pressure technologies for use within ambulatory cardiac monitoring products and services. The company was formerly known as iRhythm Technologies, Inc. and changed its name to iRhythm Holdings, Inc. in January 2026. iRhythm Holdings, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
